Advertisement

Topics

Balancing early access with uncertainties in evidence for drugs authorized by prospective case series - systematic review of reimbursement decisions.

07:00 EST 30th January 2018 | BioPortfolio

Summary of "Balancing early access with uncertainties in evidence for drugs authorized by prospective case series - systematic review of reimbursement decisions."

To review clinical and cost-effectiveness evidence underlying reimbursement decisions relating to drugs whose authorization mainly is based on evidence from prospective case series.

Affiliation

Journal Details

This article was published in the following journal.

Name: British journal of clinical pharmacology
ISSN: 1365-2125
Pages:

Links

DeepDyve research library

PubMed Articles [20150 Associated PubMed Articles listed on BioPortfolio]

Brand vs generic adverse event reporting patterns: An authorized generic-controlled evaluation of cardiovascular medications.

Some public scepticism exists about generics in terms of whether brand and generic drugs produce identical outcomes. This study explores whether adverse event (AE) reporting patterns are similar betwe...

A checklist for managed access programmes for reimbursement co-designed by Canadian patients and caregivers.

Reimbursement decisions on orphan drugs carry significant uncertainty, and as the amount increases, so does the risk of making a wrong decision, where harms outweigh benefits. Consequently, patients o...

The patient's safety and access to experimental drugs after the termination of clinical trials: regulations and trends.

Participants' rights and safety must be guaranteed not only while a clinical trial is being conducted but also when a clinical trial finishes. The criteria for post-trial access to experimental drugs,...

Do systematic reviews address community healthcare professionals' wound care uncertainties? Results from evidence mapping in wound care.

Complex wounds such as leg and foot ulcers are common, resource intensive and have negative impacts on patients' wellbeing. Evidence-based decision-making, substantiated by high quality evidence such ...

Analysis of Late AMNOG Benefit Assessments.

Since 2011, new drugs are assessed at the time of launch in Germany (AMNOG). Based on this early benefit assessment (EBA), drug prices are negotiated. At this time, the evidence base might be weak. A ...

Clinical Trials [6745 Associated Clinical Trials listed on BioPortfolio]

Evaluation of a New Regional Organization to Promote Access to Renal Transplantation

Patients with terminal chronic kidney disease (CRD) need renal function supplementation, namely dialysis or renal transplantation. Transplantation is the most efficient and cost-effective ...

Conventional vs. Sensor Guided Soft Tissue Balancing in TKA RCT

To ensure a successful outcome after total knee replacement (TKR) soft tissue balance and proper implant position are very important during the surgical procedure. Soft tissues are structu...

MaxART: Early Access to ART for All in Swaziland

The purpose of this study is to evaluate the feasibility, acceptability, clinical outcomes, affordability, and scalability of offering early antiretroviral treatment to all HIV-positive in...

Pilot Study to Improve Access to Early Intervention for Autism in Africa

This Mentored Career Development Award will lay the foundation for a career focused on addressing 2 specific Grand Challenges in Global Mental Health priorities: 1) improving child access ...

The Boston Scientific ACCESS Trial

The Boston Scientific ACCESS trial seeks to study the safety and to evaluate the success of the Fusion™ Vascular Access Graft for patients in need of early vascular access for hemodialys...

Medical and Biotech [MESH] Definitions

A preconceived judgment made without adequate evidence and not easily alterable by presentation of contrary evidence.

Work consisting of the designation of an article or book as retracted in whole or in part by an author or authors or an authorized representative. It identifies a citation previously published and now retracted through a formal issuance from the author, publisher, or other authorized agent, and is distinguished from RETRACTION OF PUBLICATION, which identifies the citation retracting the original published item.

Methods to determine in patients the nature of a disease or disorder at its early stage of progression. Generally, early diagnosis improves PROGNOSIS and TREATMENT OUTCOME.

Unauthorized access to personal information to obtain medical care or drugs, or to submit fraudulent billing for services. (from https://oig.hhs.gov/fraud/medical-id-theft/index.asp)

An Act that amends Title XVIII of the Social Security Act to repeal the Medicare sustainable growth rate, that strengthens Medicare access by improving physician payments, and that reauthorizes the Children's Health Insurance Program (CHIP).

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Searches Linking to this Article